Obama Pharma LTD

Obama Pharma LTD

Obama Pharma LTD is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Obama Pharma LTD also spends a leading amount on research and development, close to $8 billion annually. While Obama Pharma LTD historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Obama Pharma LTD sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales.

• Business Type: Distributor/Wholesaler
• Main Products: Pain Medications, Pharmaceutical products, Steroids, Weight gainer, Supplements, Cardio Medications,
• Main Markets: America, Africa, Asia, Caribbean, Europe, Oceania, Middle East, WorldWide
• Established year: 2002
• Total Annual Revenue: Above US$100 Million
• Export Percentage: 91% - 100%
• Address: 235 E 42ND ST NEW YORK NY 10017
• Phone Number : Membership Required
• Country: United States
• Key Products: Pain Medications, Pharmaceutical products, Steroids, Weight gainer, Supplements, Cardio Medications,
• Other Products: Research Chemicals, Pharmaceutical Drugs, Stimulants